Trials / Recruiting
RecruitingNCT06880679
Ultrasound Acute Chest Syndrome Sickle Cell Disease
Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Detailed description
Acute chest syndrome (ACS) is a complication of sickle cell disease where individuals have symptoms of fever, low oxygen levels or difficulty breathing in the setting of a new lung finding on chest x-ray. Chest x-ray is a useful tool to identify it but has some side effects. The investigators think ultrasound will be an equally feasible, reliable tool and minimize some of the side effects associated with chest x-ray. Ultrasound is a non-invasive was to obtain an image that does not require radiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Point of Care Ultrasound | Point of Care Ultrasound during hospitalization |
Timeline
- Start date
- 2025-04-08
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2025-03-18
- Last updated
- 2026-04-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06880679. Inclusion in this directory is not an endorsement.